Investor alert: law offices of howard g. smith announces investigation of aquestive therapeutics, inc. (aqst) on behalf of investors

Bensalem, pa--(business wire)---- $aqst #classaction--law offices of howard g. smith announces an investigation on behalf of aquestive therapeutics, inc. (“aquestive” or the “company”) (nasdaq: aqst) investors concerning the company's possible violations of federal securities laws. aquestive is a specialty pharmaceutical company. its most advanced proprietary product candidate is libervant, a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures. on december 2, 2019, aquestive
AQST Ratings Summary
AQST Quant Ranking